More than 120 international researchers, physicians and technicians from five different university institutes and hospitals (Department of Pediatrics, Institute of Pathology, Institute for Computational Biomedicine, Department of Internal Medicine and Institute of Pharmacology) and four different EMBL Units (3 in Heidelberg: Directors’ Research, Genome Biology and Structural and Computational Biology and 1 in Monterotondo: Mouse Biology) work in eight groups on important molecular medicine topics.

Members: Diseases of mRNA metabolism
(Blood Diseases)
Group Leaders: Matthias Hentze and Andreas Kulozik

Members: Molecular pathogenesis of colorectal cancer and development of novel approaches for early detection, diagnosis and prevention
(Cancer Early Detection)
Group Leaders: Peer Bork and Magnus von Knebel Doeberitz

Members: Molecular mediators of chronic pain
(Chronic Pain)
Group Leaders: Paul Heppenstall, Rohini Kuner and Jan Siemens

Members: Chronik Kidney Disease
(Chronik Kidney Disease)
Group Leaders: Christoph Merten, Rainer Pepperkok, Matthias Gaida and Julio Saez-Rodriguez

Members: Iron homeostasis in health and disease
(Iron Homeostasis)
Group Leaders: Matthias Hentze and Martina Muckenthaler

Members: Molecular Pediatric Oncology
(Molecular Pediatric Oncology)
Group Leaders: Jan Korbel and Andreas Kulozik

Members: Stem Cell–Niche Networks in Ageing and Disease
(Stem Cell–Niche Networks)
Group Leaders: Judith Zaugg and Caroline Pabst, Anthony D. Ho, Carsten Müller–Tidow

Members: Systems Medicine of Cancer Drugs
(Systems Medicine of Cancer Drugs)
Group Leaders: Wolfgang Huber and Sascha Dietrich